NCT06139406: A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer |
|
|
| Recruiting | 1 | 70 | Europe, RoW | JNJ-87801493, JNJ-80948543, JNJ-75348780 | Janssen Research & Development, LLC | Lymphoma, Non-Hodgkin | 07/26 | 07/26 | | |
NCT05424822: A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) |
|
|
| Recruiting | 1 | 220 | Europe, US, RoW | JNJ-80948543 | Janssen Research & Development, LLC | Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | 07/24 | 11/26 | | |
